AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28591084 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ketamine 1 mg/kg
Number of subjects: 90
Study 28591084 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 mL normal saline instilled in the wound)
Number of subjects: 90
Study 26371370 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mm umbilical port and laparoscope (5LH)
Number of subjects: 78
Study 26371370 — intervention group
Group type: COMPARATOR
Intervention: 10-mm umbilical port and laparoscope (10LH)
Number of subjects: 78
Study 25394438 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium (Na) bicarbonate infusion
Number of subjects: 150
Study 25394438 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) + Sodium Chloride (NaCl)
Number of subjects: 150
Study 25394438 — intervention group
Group type: COMPARATOR
Intervention: Sodium Chloride (NaCl)
Number of subjects: 150
Study 23383117 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical monitoring plus laboratory monitoring
Number of subjects: 459
Study 23383117 — intervention group
Group type: COMPARATOR
Intervention: Clinical monitoring alone
Number of subjects: 459
Study 20952003 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 U botulinum toxin-A intradetrusor injections excluding the trigone (detrusor arm)
Number of subjects: 36
Study 20952003 — intervention group
Group type: COMPARATOR
Intervention: 200 U intradetrusor plus 100 U intratrigonal injections (combined arm)
Number of subjects: 36
Study 19391536 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Yaoyangguan (GV 3), Dachangshu (BL 25), Guanyuanshu (BL 26), Xiaochangshu (BI. 27) plus blood-letting puncture at Weizhong (BL 40)
Number of subjects: 100
Study 19391536 — intervention group
Group type: COMPARATOR
Intervention: Traction combined with electroacupuncture at Jiaji (EX-B 2), Shenshu (BL 23), Dachangshu (BL 25)
Number of subjects: 100
Study 16805720 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 0
Study 15460215 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat
Number of subjects: 25302
Study 15460215 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 25302
Study 11299091 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean protein intake (upper quartile: 8.7-35.2 g/day)
Number of subjects: 200
Study 9161933 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT)
Number of subjects: 300
Study 8203790 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (group D, n = 60)
Number of subjects: 120
Study 8203790 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group P, n = 60)
Number of subjects: 120
Study 8203790 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (group D)
Number of subjects: 120
Study 8203790 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group P)
Number of subjects: 120
Study 3441747 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (i.d.) administration of 2 micrograms
Number of subjects: 58
Study 3441747 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (i.m.) administration of 20 micrograms
Number of subjects: 58
Study 3441747 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous administration of 2 micrograms
Number of subjects: 58
Study 3441747 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (i.d.) and Intramuscular (i.m.) routes
Number of subjects: 58
Study 29504671 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNC 6 L/minute
Number of subjects: 21
Study 29504671 — intervention group
Group type: COMPARATOR
Intervention: nCPAP 3 cmH2 O
Number of subjects: 21
Study 27605403 — intervention group
Group type: EXPERIMENTAL
Intervention: AHEI (2010 Alternate Healthy Eating Index)
Number of subjects: 12406
Study 24985962 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide and abiraterone in combination with standard-of-care
Number of subjects: 0
Study 23615395 — intervention group
Group type: EXPERIMENTAL
Intervention: Theobromine (0.0011 mol/l)
Number of subjects: 30
Study 23615395 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF toothpaste slurry (0.0789 mol/l F)
Number of subjects: 30
Study 23615395 — intervention group
Group type: COMPARATOR
Intervention: Artificial saliva
Number of subjects: 30
Study 19818785 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of immunosuppressive therapy (azathioprine) and 3 infusions of infliximab
Number of subjects: 133
Study 19818785 — intervention group
Group type: COMPARATOR
Intervention: Conventional corticosteroids
Number of subjects: 133
Study 19027269 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 270
Study 19027269 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination antipsychotic treatment
Number of subjects: 270
Study 19027269 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 270
Study 19027269 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 270
Study 19027269 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 270
Study 19027269 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 270
Study 15705990 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs)
Number of subjects: 27
Study 15705990 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no ICS treatment)
Number of subjects: 27
Study 14504146 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG guidance with a Seldinger guide wire (ID-A)
Number of subjects: 114
Study 14504146 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG guidance with saline 10% used as an exploring electrode (ID-B)
Number of subjects: 114
Study 14504146 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter rotation and advancement until all three lumina could be aspirated easily (ID-C)
Number of subjects: 114
Study 14504146 — intervention group
Group type: COMPARATOR
Intervention: Post-procedural chest X-ray (CXR)
Number of subjects: 114
Study 10372700 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA; 5 mg/day)
Number of subjects: 0
Study 10372700 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen plus MPA (0.625 mg/day conjugated equine estrogen and 5 mg/day MPA)
Number of subjects: 0
Study 10372700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10372700 — intervention group
Group type: COMPARATOR
Intervention: Estrogen alone
Number of subjects: 0
Study 8675938 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric evaluation and management (GEM)
Number of subjects: 160
Study 8675938 — intervention group
Group type: COMPARATOR
Intervention: Usual primary care (UPC)
Number of subjects: 160
Study 1801057 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional low protein diet (0.6 g/kg/day protein, 800 mg phosphate; n = 33)
Number of subjects: 95
Study 1801057 — intervention group
Group type: EXPERIMENTAL
Intervention: Low phosphate diet (providing approximately 1000 mg phosphate plus an orally administered phosphate binder, minimum protein intake 0.8 g/kg/day; n = 30)
Number of subjects: 95
Study 1801057 — intervention group
Group type: COMPARATOR
Intervention: Control (minimum protein intake 0.8 g/kg/day, no phosphate restriction; n = 32)
Number of subjects: 95
Study 6859212 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofocal convex lenses (+1.25 D over far Rx)
Number of subjects: 120
Study 6859212 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocals (+1.5 D near adds)
Number of subjects: 120
Study 6859212 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (no. 1 pink tint)
Number of subjects: 120
Study 6859212 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofocal treatment
Number of subjects: 120
Study 6859212 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal treatment
Number of subjects: 120
Study 30904839 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice a week programme (n=20)
Number of subjects: 60
Study 30904839 — intervention group
Group type: EXPERIMENTAL
Intervention: Once a week programme (n=20)
Number of subjects: 60
Study 30904839 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (n=20)
Number of subjects: 60
Study 28166914 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-tubercular therapy (ATT) for 6 months
Number of subjects: 100
Study 28166914 — intervention group
Group type: COMPARATOR
Intervention: No anti-tubercular therapy (no ATT)
Number of subjects: 100
Study 28166914 — intervention group
Group type: EXPERIMENTAL
Intervention: ATT
Number of subjects: 100
Study 27016906 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative Treatment (CT), n = 42
Number of subjects: 84
Study 27016906 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Treatment (ST), n = 42
Number of subjects: 84
Study 27016906 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative Treatment (CT), n = 41 (after follow-up)
Number of subjects: 84
Study 27016906 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Treatment (ST), n = 40 (after follow-up)
Number of subjects: 84
Study 25124998 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-323-3p
Number of subjects: 200
Study 25124998 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-652
Number of subjects: 200
Study 25124998 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-27b
Number of subjects: 200
Study 25124998 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-323-3p and miR-652
Number of subjects: 200
Study 25124998 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-103
Number of subjects: 200
Study 25124998 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-208a
Number of subjects: 200
Study 22080631 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home cognitive, physical, and functional rehabilitation over a 3-month period via a social worker or master's level psychology technician utilizing telemedicine
Number of subjects: 21
Study 22080631 — intervention group
Group type: COMPARATOR
Intervention: Usual care (sporadic rehabilitation)
Number of subjects: 21
Study 19183094 — intervention group
Group type: EXPERIMENTAL
Intervention: Information framing emphasizing cervical cancer protection
Number of subjects: 635
Study 19183094 — intervention group
Group type: COMPARATOR
Intervention: Alternate versions of the descriptive paragraph
Number of subjects: 635
Study 17546496 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate rental housing assistance
Number of subjects: 630
Study 17546496 — intervention group
Group type: COMPARATOR
Intervention: Assistance finding housing according to local standard practice
Number of subjects: 630
Study 15102635 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard postural drainage chest physiotherapy (SPT)
Number of subjects: 20
Study 15102635 — intervention group
Group type: COMPARATOR
Intervention: Modified physiotherapy regimen (MPT) without head-down tilt
Number of subjects: 20
Study 15102635 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking during SPT
Number of subjects: 20
Study 11772148 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide sustained-release (SR) 1.5 mg/day
Number of subjects: 1195
Study 9090347 — intervention group
Group type: EXPERIMENTAL
Intervention: dl-fenfluramine
Number of subjects: 20
Study 9090347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7948822 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic biliary drainage (group Ia)
Number of subjects: 59
Study 7948822 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (group Ib)
Number of subjects: 59
Study 7948822 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic biliary drainage and surgery (both groups)
Number of subjects: 59
Study 7948822 — intervention group
Group type: COMPARATOR
Intervention: Deterioration of T lymphocyte function
Number of subjects: 59
Study 7948822 — intervention group
Group type: COMPARATOR
Intervention: T lymphocyte function
Number of subjects: 59
Study 3365665 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (8 mg/kg)
Number of subjects: 46
Study 3365665 — intervention group
Group type: COMPARATOR
Intervention: Low-dose metoclopramide (0.8 mg/kg)
Number of subjects: 46
Study 30711879 — intervention group
Group type: EXPERIMENTAL
Intervention: Static balance
Number of subjects: 90
Study 30711879 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle strength of knee extensors, knee flexors, plantarflexors, and dorsiflexors
Number of subjects: 90
Study 30711879 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional balance (Mini-BESTest)
Number of subjects: 90
Study 30711879 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate regression models including postural sway, muscle strength, age, and gender
Number of subjects: 90
Study 30711879 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural sway
Number of subjects: 90
Study 30711879 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle strength
Number of subjects: 90
Study 30711879 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance
Number of subjects: 90
Study 27873046 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based lifestyle modification program (Precision Nutrition Coaching)
Number of subjects: 35
Study 27873046 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 26934167 — intervention group
Group type: EXPERIMENTAL
Intervention: ZEEP (zero end-expiratory pressure) group
Number of subjects: 27
Study 26934167 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP (8 cm H2O positive end-expiratory pressure) group
Number of subjects: 27
Study 24376273 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral artesunate
Number of subjects: 72
Study 21960669 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous peramivir (600 mg)
Number of subjects: 21
Study 21960669 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oseltamivir (75 mg)
Number of subjects: 21
Study 21960669 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rimantadine (100 mg)
Number of subjects: 21
Study 21960669 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of peramivir with oseltamivir or rimantadine
Number of subjects: 21
Study 19046761 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-grass-pollen sublingual immunotherapy tablets (300 IR)
Number of subjects: 278
Study 19046761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study 17332443 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg pravastatin
Number of subjects: 355
Study 17332443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study 15111338 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklets
Number of subjects: 328
Study 15111338 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotapes
Number of subjects: 328
Study 15111338 — intervention group
Group type: EXPERIMENTAL
Intervention: Information provided
Number of subjects: 328
Study 11439376 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand brace worn at night for 4 weeks
Number of subjects: 83
Study 11439376 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 83
Study 9704776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cerclage (n = 19)
Number of subjects: 39
Study 9704776 — intervention group
Group type: COMPARATOR
Intervention: Conservative management (n = 20)
Number of subjects: 39
Study 8582132 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) infusion at 24 mU kg‐1 min‐1
Number of subjects: 7
Study 8582132 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) infusion at 12 mU kg‐1 min‐1
Number of subjects: 7
Study 8582132 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) infusion at 6 mU kg‐1 min‐1
Number of subjects: 7
Study 8582132 — intervention group
Group type: COMPARATOR
Intervention: Control (saline infusion)
Number of subjects: 7
Study 1978069 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine 120 mg per day
Number of subjects: 1215
Study 1978069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1215
Study 69882 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoamine-oxidase inhibitors (clorgyline and pargyline)
Number of subjects: 2
Study 69882 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 2
Study 31407967 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC)
Number of subjects: 408
Study 31407967 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical model using predictors (clinical stage N2 or N3, presence of axillary lymphadenopathy at US after NAC, tumor size reduction less than 50% at MRI, Ki‐67 negativity, hormone receptor positivity, and HER2 negativity)
Number of subjects: 408
Study 31407967 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified risk score of 1
Number of subjects: 408
Study 28237085 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ-LNS (small-quantity lipid-based nutrient supplement)
Number of subjects: 2711
Study 28237085 — intervention group
Group type: COMPARATOR
Intervention: Iron-folic acid
Number of subjects: 2711
Study 28237085 — intervention group
Group type: COMPARATOR
Intervention: Multiple micronutrients
Number of subjects: 2711
Study 26005768 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Supported Discharge (ESD) in a day unit
Number of subjects: 154
Study 26005768 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Supported Discharge (ESD) at home
Number of subjects: 154
Study 26005768 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment in the municipality (control group)
Number of subjects: 154
Study 26005768 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Supported Discharge (ESD) models
Number of subjects: 154
Study 23690321 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site facilitation and learning collaboratives
Number of subjects: 23
Study 23690321 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 23
Study 21559908 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-coaxial incision (2.2 mm)
Number of subjects: 76
Study 21559908 — intervention group
Group type: COMPARATOR
Intervention: Standard incision (2.8 mm)
Number of subjects: 76
Study 19408007 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.609-km walk at 1.34 m s(‐1)
Number of subjects: 26
Study 19408007 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.609-km jog at 2.23 m s(‐1)
Number of subjects: 26
Study 19408007 — intervention group
Group type: COMPARATOR
Intervention: Both walking and jogging activities
Number of subjects: 26
Study 17152005 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in the IL‐2 gene (IVS1‐100G (rs2069762) and Ex2‐34G (rs2069763))
Number of subjects: 118
Study 17152005 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in the IL‐10 gene
Number of subjects: 118
Study 17152005 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in the IL‐12R genes
Number of subjects: 118
Study 17152005 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in the IL‐4RA and IL‐12B genes
Number of subjects: 118
Study 17152005 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs
Number of subjects: 118
Study 15163449 — intervention group
Group type: EXPERIMENTAL
Intervention: Word Memory Test (WMT)
Number of subjects: 519
Study 15163449 — intervention group
Group type: COMPARATOR
Intervention: Test of Memory Malingering (TOMM)
Number of subjects: 519
Study 15163449 — intervention group
Group type: COMPARATOR
Intervention: Computerized Assessment of Response Bias (CARB)
Number of subjects: 519
Study 11447496 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 102
Study 11447496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 9727709 — intervention group
Group type: EXPERIMENTAL
Intervention: IPPV (high rate 60‐80/min, low peak pressures)
Number of subjects: 76
Study 9727709 — intervention group
Group type: COMPARATOR
Intervention: HFOV (aiming at optimization of lung volume)
Number of subjects: 76
Study 7736902 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 27
Study 7736902 — intervention group
Group type: COMPARATOR
Intervention: Control (diet only or diet and sulphonylurea)
Number of subjects: 27
Study 2341458 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenol cauterisation
Number of subjects: 249
Study 2341458 — intervention group
Group type: COMPARATOR
Intervention: Wedge excision
Number of subjects: 249
Study 329848 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 0.2 mg + Neostigmine 1.0 mg
Number of subjects: 0
Study 329848 — intervention group
Group type: COMPARATOR
Intervention: Atropine + Neostigmine (exact dosage not specified)
Number of subjects: 0
Study 30948215 — intervention group
Group type: EXPERIMENTAL
Intervention: Whip-stitch (WS) technique
Number of subjects: 10
Study 30948215 — intervention group
Group type: COMPARATOR
Intervention: Simple suture technique (SST)
Number of subjects: 10
Study 27838943 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone (two consecutive doses of 12 mg intramuscularly, 24 hours apart)
Number of subjects: 40
Study 27838943 — intervention group
Group type: COMPARATOR
Intervention: Control (saline as a placebo)
Number of subjects: 40
Study 25459995 — intervention group
Group type: COMPARATOR
Intervention: Probiotic strains (Bifidobacterium longum, B. lactis, Lactobacillus acidophilus, L. rhamnosus, L. plantarum, and Pediococcus pentosaceus) at a dose of 10^9 colony forming units/g, administered twice daily for 1 week.
Number of subjects: 29
Study 25459995 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered twice daily for 1 week.
Number of subjects: 29
Study 23787721 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan and an ACE inhibitor (dual RAAS blockade)
Number of subjects: 5010
Study 23787721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5010
Study 16373275 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 116
Study 16373275 — intervention group
Group type: COMPARATOR
Intervention: Gluten-free diet supplemented with oats
Number of subjects: 116
Study 16700140 — intervention group
Group type: EXPERIMENTAL
Intervention: Involuntary outpatient commitment (OPC) sustained for 6 months or longer
Number of subjects: 0
Study 16700140 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient visits frequency
Number of subjects: 0